JNJ
JNJ
NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals

Johnson & Johnson

$257.21
-0.39 (-0.15%)
Analyst Consensus
Buy
31
Analysts
Very High
Coverage
Buy 21 68%
Hold 10 32%
Sell 0 0%
Price Target
Analyst Price Target +16.5% upside
Low Target $223.02
Average Target $299.55
High Target $400.15
Current Price $257.21
Current
$257.21
Target
$299.55
$223.02 $299.55 avg $400.15
Scenario Analysis
Bear Case
$223.02
-13.3%
Low target
Base Case
$299.55
+16.5%
Avg target
Bull Case
$400.15
+55.6%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$274.90
-6.4% from high
52-Week Low
$164.23
+56.6% from low
50-Day SMA
$219.25
+17.3% vs SMA
200-Day SMA
$185.17
+38.9% vs SMA
RSI (14)
88.6
Overbought
Target vs 52W High
$299.55
+9.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +11.9%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +16.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.8%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +30.5%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +172.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.7%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +173.7%